Glen Eagle Advisors’s Innospec IOSP Stock Holding History

Glen Eagle Advisors’s Portfolio IOSP Stock Details IOSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-78	Closed	-$7.12K	–	839
2019 Q2	$7.12K	Buy	+78	New	+$6.57K	﹤0.01%	561

Other funds holding IOSP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Glen Eagle Advisors's IOSP Position: Q3 2019 in Review

Glen Eagle Advisors sold out of Innospec (IOSP) in Q3 2019, closing a stake of 78 shares — an estimated $7.12K sold.

Glen Eagle Advisors first reported a position in IOSP in Q2 2019 and held it in 1 quarter. The position peaked at $7.12K in Q2 2019. 207 funds tracked by Wall St. Rank hold IOSP as of Q3 2019.

Glen Eagle Advisors reported no remaining Innospec position as of Q3 2019 after selling out during the quarter.
Glen Eagle Advisors sold 78 Innospec shares in Q3 2019, an estimated $7.12K.
Glen Eagle Advisors first reported a position in Innospec in Q2 2019 and held it in 1 quarter.
Glen Eagle Advisors's Innospec position peaked at $7.12K in Q2 2019.
207 funds tracked by Wall St. Rank held Innospec as of Q3 2019.

Based on Glen Eagle Advisors's 13F filing for Q3 2019, filed 13 Aug 2024.